Page 141 - CW E-Magazine (31-10-2023)

Top Stories

PRODUCT SAFETY

Dabur’s international arms face lawsuits in US,

Canada over cancer allegations

Dabur India said that three of its the United States District Court for the are about 5,400 cases in MultiDistrict
international subsidiaries are among the Northern District of Illinois,” the FMCG Litigation, which name Namaste, Der-
companies being sued in the US and company stated. “Currently, the cases moviva and DINTL as defendants along
Canada by certain customers alleging are in the pleadings and early discovery with certain other industry players.
that use of their hair relaxer products phases of litigation. There are various
caused ovarian cancer, uterine cancer motions pending as well,” it added. “Certain consumers in the hair
and other health issues. relaxer product industry have alleged
Financial impact that some industry players/defendants
The three international subsidia- “Since we are in the initial stage of sold and/or manufactured hair relaxer
ries that are facing “multiple lawsuits at litigation, any fi nal quantum of claim products that contain certain chemicals
both Federal and State Courts in the two amount is neither probable nor esti- and that the use of these hair relaxer
countries include Namaste Laboratories mable. However, the company is dis- product has caused ovarian cancer,
LLC, Dermoviva Skin Essentials Inc. closing the details of aforesaid pending uterine cancer and other health issues
and Dabur International Ltd. (DINTL), litigations, since the cumulative value in the users,” the company added.
it said in a BSE fi ling on OCTOBER 18. of impact on account of legal defence
“Cases have been fi led in both federal cost is expected to breach the materia- “Namaste, Dermoviva and DINTL
and state courts in the United States and lity threshold under the Listing Regula- deny liability and have retained counsel
in Canada. tions,” Dabur India added. to defend them in these lawsuits as these
allegations are based on unsubstantia-
The federal cases were consolidated Over 5,000 cases ted and incomplete study,” Dabur India
as a MultiDistrict Litigation, before The company said that currently there stated.

Centre assures renewable energy stakeholders of

early resolution of regulatory issues

Green hydrogen developers and hydrogen and its derivatives export Launched in January 2023, the
renewable energy stakeholders have fi eld. National Green Hydrogen Mission
fl agged issues like regulatory provi- (NGHM) has a total outlay of Rs.
sions for enabling dual connectivity, He further announced that no com- 19,744-crore. It envisages production
certain contractual conditions, demand promise would be made with regard to of 5-mtpa of green hydrogen by 2030
charges levied by States and other aspects grid security, while ensuring production with an associated renewable energy
related to SEZ, with the Centre. of green hydrogen stayed competitive. addition of 125-GW.

These issues were raised in a meet- QCO order for lauric acid postponed
ing with Power and Renewable Energy
Minister, Mr. R.K. Singh recently. The Ministry of Chemicals and chemicals and several foreign manufac-
Fertilisers has postponed the implemen- turers are fi nding the BIS process very
Mr. Singh assured the industry that tation of the Quality Control Order on diffi cult to comply with. According to
all their demands will be looked into lauric acid – an oleochemical – to April Mr. Manoj Jha, Convenor, Indian Sur-
and the government will take all pos- 24, 2024. factants Group, no foreign manufacturer
sible steps for the resolution of their of lauric acid has been able to get regi-
outstanding issues at the earliest. The The Bureau of Indian Standards stration. “The BIS process for Foreign
minister also said India is committed to (BIS) is in charge of implementing the Manufacturer Certifi cation Scheme
being a competitive player in the green order which is applicable on imported needs a review,” he said.

Chemical Weekly October 31, 2023 141

Contents Index to Advertisers Index to Products Advertised